Early effects of dexamethasone and anti-VEGF therapy in an inflammatory corneal neovascularization model
Author:
Funder
Crown Princess Margareta's Foundation
The Swedish Research Council
Publisher
Elsevier BV
Subject
Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology
Reference61 articles.
1. Anti-FGF2 approaches as a strategy to compensate resistance to anti-VEGF therapy: long-pentraxin 3 as a novel antiangiogenic FGF2-antagonist;Alessi;Eur. Cytokine Netw.,2009
2. Effect of subconjunctival and intraocular bevacizumab injections on corneal neovascularization in a corneal model;Avisar;Curr. Eye Res.,2010
3. Subconjunctival bevacizumab injection for corneal neovascularization;Bahar;Cornea,2008
4. Tissue distribution of dexamethasone in feline ocular structures following single topical application of dexamethasone as an ointment or suspension;Bessonova;Vet. Ophthalmol.,2011
5. Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis;Bock;Investig. Ophthlamol. Vis. Sci.,2007
Cited by 52 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Intravitreal anti-vascular endothelial growth factor (bevacizumab) in nanophthalmic exudative macular detachment – A new treatment modality;Journal of Ophthalmic Research and Practice;2023-12-02
2. A double-crosslinked nanocellulose-reinforced dexamethasone-loaded collagen hydrogel for corneal application and sustained anti-inflammatory activity;Acta Biomaterialia;2023-12
3. Determination of the Toxicity Preferences of Ocular Drug Delivery System by Comparing Two Different Toxicity Bioassays;ASSAY and Drug Development Technologies;2023-10-01
4. DZ2002 alleviates corneal angiogenesis and inflammation in rodent models of dry eye disease via regulating STAT3-PI3K-Akt-NF-κB pathway;Acta Pharmacologica Sinica;2023-08-21
5. Ocular therapies with biomacromolecules: From local injection to eyedrop and emerging noninvasive delivery strategies;Advanced Drug Delivery Reviews;2023-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3